OGT and breast carcinoma: Thus, our data suggests that KFL8 plays a key role in regulating CSCs phenotypes in vitro, forms a feed-forward regulation with OGT, regulates triple negative breast tumor growth in vivo and associates with poor clinical outcome in breast cancer patients.